<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Z</submitter><funding>Chongqing Science Fund</funding><funding>Chongqing Medical University</funding><funding>Doctor Research Project of Chongqing</funding><funding>National Natural Science Foundation of China</funding><funding>Chongqing Municipal Education Commission</funding><pagination>e20241248</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11748990</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>222(3)</volume><pubmed_abstract>Hematopoietic stem cells (HSCs) are susceptible to replication stress, which is a major contributor to HSC defects in Fanconi anemia (FA). Here, we report that HSCs relax the global chromatin by downregulating the expression of a chromatin architectural protein, DEK, in response to replication stress. DEK is abnormally accumulated in bone marrow (BM) CD34+ cells from patients with FA and in Fancd2-deficient HSCs. DEK haploinsufficiency promotes chromatin relaxation, replication stress relief, and function recovery of Fancd2-deficient HSCs. Furthermore, inhibition of DEK restores the proliferation of FA CD34+ cells in vitro and enhances their engraftment in vivo. Mechanistically, the activating transcription factor 2 (ATF2), specifically phosphorylated ATF2 at Thr69/71, was identified as a </pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia.</pubmed_title><pmcid>PMC11748990</pmcid><funding_grant_id>82170115</funding_grant_id><funding_grant_id>CSTB2022BSXM-JCX0005</funding_grant_id><funding_grant_id>CSTB2022NSCQ-JQX0032</funding_grant_id><funding_grant_id>KJQN202400465</funding_grant_id><funding_grant_id>W0156</funding_grant_id><funding_grant_id>CSTB2023NSCQ-LZX0052</funding_grant_id><pubmed_authors>Xie Y</pubmed_authors><pubmed_authors>Deng J</pubmed_authors><pubmed_authors>Wu F</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Xiao J</pubmed_authors><pubmed_authors>Lei Y</pubmed_authors><pubmed_authors>Zeng H</pubmed_authors><pubmed_authors>Gao S</pubmed_authors><pubmed_authors>Chen T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of DEK restores hematopoietic stem cell function in Fanconi anemia.</name><description>Hematopoietic stem cells (HSCs) are susceptible to replication stress, which is a major contributor to HSC defects in Fanconi anemia (FA). Here, we report that HSCs relax the global chromatin by downregulating the expression of a chromatin architectural protein, DEK, in response to replication stress. DEK is abnormally accumulated in bone marrow (BM) CD34+ cells from patients with FA and in Fancd2-deficient HSCs. DEK haploinsufficiency promotes chromatin relaxation, replication stress relief, and function recovery of Fancd2-deficient HSCs. Furthermore, inhibition of DEK restores the proliferation of FA CD34+ cells in vitro and enhances their engraftment in vivo. Mechanistically, the activating transcription factor 2 (ATF2), specifically phosphorylated ATF2 at Thr69/71, was identified as a </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-06T19:22:04.435Z</modification><creation>2026-06-04T03:12:48.069Z</creation></dates><accession>S-EPMC11748990</accession><cross_references><pubmed>39836085</pubmed><doi>10.1084/jem.20241248</doi></cross_references></HashMap>